Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antagonistic human FcγRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivo.
Roghanian A, Teige I, Mårtensson L, Cox KL, Kovacek M, Ljungars A, Mattson J, Sundberg A, Vaughan AT, Shah V, Smyth NR, Sheth B, Chan HT, Li ZC, Williams EL, Manfredi G, Oldham RJ, Mockridge CI, James SA, Dahal LN, Hussain K, Nilsson B, Verbeek JS, Juliusson G, Hansson M, Jerkeman M, Johnson PW, Davies A, Beers SA, Glennie MJ, Frendéus B, Cragg MS. Roghanian A, et al. Among authors: jerkeman m. Cancer Cell. 2015 Apr 13;27(4):473-88. doi: 10.1016/j.ccell.2015.03.005. Cancer Cell. 2015. PMID: 25873171 Free article.
Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL.
Husby S, Bæch-Laursen C, Eskelund CW, Favero F, Jespersen JS, Hutchings M, Pedersen LB, Niemann CU, Weischenfeldt J, Räty R, Larsen TS, Kolstad A, Jerkeman M, Grønbæk K. Husby S, et al. Among authors: jerkeman m. Leukemia. 2022 Dec;36(12):2912-2916. doi: 10.1038/s41375-022-01725-8. Epub 2022 Oct 23. Leukemia. 2022. PMID: 36274067 No abstract available.
A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia.
Ljungars A, Mårtensson L, Mattsson J, Kovacek M, Sundberg A, Tornberg UC, Jansson B, Persson N, Emruli VK, Ek S, Jerkeman M, Hansson M, Juliusson G, Ohlin M, Frendéus B, Teige I, Mattsson M. Ljungars A, et al. Among authors: jerkeman m. NPJ Precis Oncol. 2018 Sep 3;2:18. doi: 10.1038/s41698-018-0061-2. eCollection 2018. NPJ Precis Oncol. 2018. PMID: 30182064 Free PMC article.
Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study.
Pauly F, Fjordén K, Leppä S, Holte H, Björkholm M, Fluge Ø, Møller Pedersen L, Eriksson M, Isinger-Ekstrand A, Borrebaeck CA, Jerkeman M, Wingren C. Pauly F, et al. Among authors: jerkeman m. Blood Cancer J. 2016 Nov 18;6(11):e501. doi: 10.1038/bcj.2016.113. Blood Cancer J. 2016. PMID: 27858932 Free PMC article. Clinical Trial. No abstract available.
197 results